Company Profiles

driven by the PitchBook Platform

Abviris

Abviris
2014 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Developer of an immunological quick test designed to detect oral cancer screening. The company's immunological quick test uses vitro diagnostic tool which allows specific screening for the detection of HPV-related oral cavity carcinomas, enabling users to detect cancer and get results of the examination available within 15 minutes.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
Alter Teichweg 22a
22949 Ammersbek
Germany

+49 (0)41 0267 7561 4
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Abviris’s full profile, request a free trial.

Abviris Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 21-Jan-2016 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Abviris Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
Mittelständische Beteiligungsgesellschaft Schleswig-Holstein Venture Capital Minority 000 0000 000000 0

Abviris Executive Team (2)

Name Title Board
Seat
Contact
Info
Stefan Raupach General Manager, Commercial Director, Co-Owner & Co-Founder
Ralf Hilfrich Scientific and Technical Director, Co-Owner & Co-Founder